Gelonghui, January 2, 丨 Kangjian International Healthcare (03886.HK) announced that from January 1, 2024: (1) Huang Zijie has resigned as (i) Executive Director; and (ii) Chief Executive Officer; (2) Huang Junhua has resigned as Executive Director; (3) Wu Tingzhi has resigned as Executive Director; (4) Yao Yuan has resigned as Executive Director; (5) Liu Huiyi has resigned as (i) Executive Director; and (ii) He Guohua has resigned (i) as respective members of the Nomination Committee and Remuneration Committee; (6) He Guohua has resigned (i) Independent Non-Executive Director; and (ii) Audit Committee, Nomination Committee and Remuneration Committee their respective chairmen; (7) Xu Canjie has resigned (i) as an independent non-executive director; and (ii) as a member of the Nomination Committee and Remuneration Committee; and (8) Tang Zhigang has resigned as (i) an independent non-executive director; and (ii) the respective members of the Nomination Committee and Remuneration Committee.
Since 1 January 2024: (1) Independent Non-Executive Director Chen Weigen has been appointed as Chairman of the Audit Committee; (2) Chairman and Executive Director Choi Ka-chan has been appointed as Chairman of the Nomination Committee; and (3) Independent Non-Executive Director Cheung Ka-ming has been appointed as Chairman of the Remuneration Committee. Furthermore, Chairman and Executive Director Choi Ka-chan has been appointed as the Chief Executive Officer since January 1, 2024.